Pulling SEC filings + quote and writing the call…

Vivakor, Inc.
Next earnings Aug 17, 2026
$104M-revenue midstream shell bleeding $110M with $265K cash, a 0.13x current ratio, and CEO-related-party revenue — uninvestable.
Cash & equivalents $265K · FY2025
Vivakor grew revenue to $104M (+16.3%) and swung gross profit to +$37.7M, but that is the only positive line in the file. FY2025 produced a -$110M net loss (net margin -105.6%), a -$63.8M operating loss, -$15.8M of operating cash flow, and a -266.8% return on equity. The loss dwarfs revenue and the +$37.7M of gross profit, implying large impairment/below-the-line charges tied to the October 2024 Endeavor acquisition that management now says it is 'reviewing' and may seek 'strategic alternatives' for — i.e., the acquisition that built the revenue base is being questioned barely a year later.
The balance sheet is the disqualifier. Current assets are $8.22M against $61.5M of current liabilities — a 0.13x current ratio — with only $265K of cash on hand (down 59.3%). Retained earnings sit at -$204M and equity fell 65.4% to $41.3M against $76.3M of liabilities (1.85x). A company burning cash operationally with a quarter-million dollars in the bank and a ~$53M working-capital hole is a liquidity crisis that can only be plugged by more debt or dilution; shares already collapsed 95.4% (the -$318 diluted EPS reflects a reverse split), and the $677K market cap tells you the market treats the $41.3M of stated equity as unreliable.
Is VIVK a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.09M | $28.1M | $59.3M | $89.8M | $104M |
| Gross profit | $37.8K | $2.87M | $5.02M | $10.2M | $37.7M |
| Operating income | -$6.93M | -$22.7M | -$6.33M | -$22.0M | -$63.8M |
| Net income | -$7.26M | -$20.2M | -$10.8M | -$26.4M | -$110M |
| Diluted EPS | — | — | -$0.56 | -$151.32 | -$318.01 |
| Net margin | -666.6% | -72.0% | -18.3% | -29.3% | -105.6% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosed annual meeting voting results plus routine Reg FD update
Amended S-1 registering more resale shares — dilution/overhang risk
Another unregistered equity sale — continued dilution of shareholders
More unregistered shares issued; ongoing dilution amid cash strain
Filed definitive proxy for annual shareholder meeting — routine governance
Filed definitive proxy for annual shareholder meeting — routine governance
Amended resale registration statement — pending share overhang
Q1'26 report: losses continue against $110M FY25 deficit and thin liquidity
Could not file 10-Q on time — late-filing notification signals reporting strain
Sources: SEC EDGAR (CIK 0001450704, latest 10-Q filed 2026-05-20) · EODHD · Proprietary analysis · as of 7/4/2026, 10:24:33 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 6:24 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2025-11-26 | Hawley Kimberly Ann CFO | Award | 25.0K @ $0.13 | $3.20K |
| 2025-11-10 | Ballengee James H. CEO | Disposed (J) | 2.98M @ $0.17 | $507K |
| 2025-11-10 | Ballengee James H. CEO | Disposed (J) | 30.1K @ $0.17 | $5.12K |
| 2024-12-02 | Ballengee James H. Chairman, President, & CEO | Award | 370K @ $0.60 | $223K |
| 2024-12-02 | Ballengee James H. Chairman, President, & CEO | Award | 5.00M @ $1.00 | $5.00M |
| 2024-12-02 | Ballengee James H. Chairman, President, & CEO | Award | 50.5K @ $1.00 | $50.5K |
| 2024-07-03 | Knapp Patrick EVP, Gen. Counsel, & Secretary | Award | 140K @ $1.78 | $250K |
| 2024-06-18 | Ballengee James H. Chairman, President, & CEO | Award | 422K @ $0.59 | $250K |
| 2024-06-03 | Ballengee James H. Chairman, President, & CEO | Buy | 1.00K @ $1.57 | $1.57K |
| 2024-05-31 | Ballengee James H. Chairman, President, & CEO | Buy | 12.6K @ $1.53 | $19.3K |
| 2024-05-30 | Ballengee James H. Chairman, President, & CEO | Buy | 15.1K @ $1.52 | $23.1K |
| 2024-05-29 | Ballengee James H. Chairman, President, & CEO | Buy | 42.1K @ $1.35 | $56.7K |
1195 tracked peers · median